2023 Fierce Biotech Next Gen
What’s beyond the leading edge of biotech and pharma?
Find us at this virtual event covering the trends and forces shaping the future of biotech and pharma.
Ready to explore your options? Connect with us now to explore how our dedicated interdisciplinary team can provide customized asset development solutions that meet your specific needs.
Featured Session
Accelerating the Path to Market for Emerging Biotech
June 13 | 1 p.m. ET
Early-stage biotech companies historically have had limited options to get their first asset to market. In most cases, they lose ownership and control of their asset by pursuing deals with larger partners or take upon themselves massive financial risk to invest in becoming a fully integrated company. In this session, we’ll discuss how some biotechs are flipping these traditional models to their advantage, empowering themselves to chart their own future, minimize launch risk, and maximize asset value.
Lee Taurman, EVP and Global Head, Syneos One
Additional Resources
Want to learn more? Explore Insights Hub for our latest perspectives, subscribe to our podcast, or click the resources below:
CAPABILITIES:
About Syneos One: Supporting You Through Every Stage of Your Asset’s Lifecycle
Full Service Commercial from Syneos Health
Full Service Development from Syneos Health
INSIGHTS:
The Win-Win of End-to-End Outsourcing for Emerging Biotech
How Clarity Can Be a Differentiator for Biotechs in Uncertain Times
Preparing and Aligning Your Biotech Organization for Commercial Success
